A multi-omics approach to understand the influence of polyphenols in ovarian cancer for precision nutrition: a mini-review

被引:0
|
作者
Tecchio Borsoi, Felipe [1 ]
Ferreira Alves, Leticia [2 ]
Neri-Numa, Iramaia Angelica [1 ]
Geraldo, Murilo Vieira [2 ]
Pastore, Glaucia Maria [1 ]
机构
[1] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Dept Food Sci & Nutr,Lab Bioflavors & Bioact Cpds, Campinas, Brazil
[2] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Campinas, Brazil
基金
巴西圣保罗研究基金会;
关键词
Big data; high-throughput technologies; natural compounds; nutrigenetics; nutrigenomics; PERSONALIZED NUTRITION; GUT MICROBIOTA; BIG DATA; NUTRIGENOMICS; CELLS; FOOD; RESVERATROL; MODULATION; SIGNATURES; MUTATIONS;
D O I
10.1080/10408398.2023.2287701
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The impact of polyphenols in ovarian cancer is widely studied observing gene expression, epigenetic alterations, and molecular mechanisms based on new 'omics' technologies. Therefore, the combination of omics technologies with the use of phenolic compounds may represent a promising approach to precision nutrition in cancer. This article provides an updated review involving the current applications of high-throughput technologies in ovarian cancer, the role of dietary polyphenols and their mechanistic effects in ovarian cancer, and the current status and challenges of precision nutrition and their relationship with big data. High-throughput technologies in different omics science can provide relevant information from different facets for identifying biomarkers for diagnosis, prognosis, and selection of specific therapies for personalized treatment. Furthermore, the field of omics sciences can provide a better understanding of the role of polyphenols and their function as signaling molecules in the prevention and treatment of ovarian cancer. Although we observed an increase in the number of investigations, there are several approaches to data acquisition, analysis, and integration that still need to be improved, and the standardization of these practices still needs to be implemented in clinical trials.
引用
收藏
页码:1037 / 1054
页数:18
相关论文
共 50 条
  • [1] Mini-review: Immunology in ovarian cancer
    Taki, Mana
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (09) : 2245 - 2251
  • [2] A multi-omics approach to understand the underlying mechanisms of obesity
    Niu, J.
    Gieger, C.
    Peters, A.
    Sharma, S.
    Grallert, H.
    DIABETOLOGIA, 2024, 67 : S108 - S108
  • [3] Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses
    Naqvi, Ilmas
    Bandyopadhyay, Anannya
    Panda, Amisha
    Hareramadas, B.
    REPRODUCTIVE SCIENCES, 2025, : 618 - 646
  • [4] Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer
    Lin, Shijuan
    Nguyen, Lily L.
    McMellen, Alexandra
    Leibowitz, Michael S.
    Davidson, Natalie
    Spinosa, Daniel
    Bitler, Benjamin G.
    MOLECULAR DIAGNOSIS & THERAPY, 2025, 29 (02) : 145 - 151
  • [5] A multi-omics approach on hereditary colorectal cancer
    Eiengard, Frida
    Rohlin, Anna
    Ellegard, Rada
    Palmeback, Pia
    Rosliden, Monica
    Andersson, Daniel Madan
    Olausson, Torbjorn
    Nordling, Margareta
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 585 - 585
  • [6] An innovative multi-omics approach for precision prevention in obesity epidemic
    Selam, Woldemariam N.
    GESUNDHEITSWESEN, 2022, 84 (08/09) : 891 - 891
  • [7] The spatial multi-omics revolution in cancer therapy: Precision redefined
    Du, Yanhua
    Ding, Xinyu
    Ye, Youqiong
    CELL REPORTS MEDICINE, 2024, 5 (09)
  • [8] Personalized analysis of human cancer multi-omics for precision oncology
    Li, Jiaao
    Tian, Jingyi
    Liu, Yachen
    Liu, Zan
    Tong, Mengsha
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2024, 23 : 2049 - 2056
  • [9] Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer
    Li, Ju-Yueh
    Li, Chia-Jung
    Lin, Li-Te
    Tsui, Kuan-Hao
    CANCER CONTROL, 2020, 27 (01)
  • [10] Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence
    Xu, Zishan
    Li, Wei
    Dong, Xiangyang
    Chen, Yingying
    Zhang, Dan
    Wang, Jingnan
    Zhou, Lin
    He, Guoyang
    CLINICA CHIMICA ACTA, 2024, 559